Terms: = Uterine cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Treatment
23 results:
1. Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/smad2/3 signaling.
Shen L; Li Y; Hu G; Song X; Wang X; Li X; Xu X
Funct Integr Genomics; 2023 Apr; 23(2):133. PubMed ID: 37081108
[TBL] [Abstract] [Full Text] [Related]
2. TGF-β signaling promotes cervical cancer metastasis via CDR1as.
Zhong G; Zhao Q; Chen Z; Yao T
Mol Cancer; 2023 Mar; 22(1):66. PubMed ID: 37004067
[TBL] [Abstract] [Full Text] [Related]
3. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical cancer via the TGF-β1/smad2/3 Pathway.
Liu P; Pei JJ; Li L; Li JW; Ke XP
Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer.
Ji X; Chu G; Chen Y; Jiao J; Lv T; Yao Q
Arch Gynecol Obstet; 2023 Mar; 307(3):903-917. PubMed ID: 35713693
[TBL] [Abstract] [Full Text] [Related]
5. Study on the mechanism of let-7a-5p in regulating the proliferation in cervical cancer cells.
Chen Z; Qiu J; Gao Y; Lu Q; Lin Y; Shi H
Clin Transl Oncol; 2022 Aug; 24(8):1631-1642. PubMed ID: 35303268
[TBL] [Abstract] [Full Text] [Related]
6. Short-term tetrabromobisphenol A exposure promotes fibrosis of human uterine fibroid cells in a 3D culture system through TGF-beta signaling.
Liu J; Yu L; Castro L; Yan Y; Clayton NP; Bushel P; Flagler ND; Scappini E; Dixon D
FASEB J; 2022 Feb; 36(2):e22101. PubMed ID: 35032343
[TBL] [Abstract] [Full Text] [Related]
7. Variances in the Expression Profile of the EMT-Related Genes in Endometrial cancer Lines In Vitro Study.
Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
[TBL] [Abstract] [Full Text] [Related]
8. SUV39H1-Mediated
Zhang L; Tian S; Zhao M; Yang T; Quan S; Song L; Yang X
Anticancer Agents Med Chem; 2021; 21(6):756-765. PubMed ID: 32698743
[TBL] [Abstract] [Full Text] [Related]
9. The effect of TGF-β signaling on regulating proliferation of uterine leiomyoma cell via ERα signaling activated by bisphenol A, octylphenol and nonylphenol
Shen Y; Lu Q; Zhang P; Wu Y; Ren M
J Cancer Res Ther; 2018 Jun; 14(Supplement):S276-S281. PubMed ID: 29970676
[TBL] [Abstract] [Full Text] [Related]
10. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
Goto M; Osada S; Imagawa M; Nishizuka M
Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
[TBL] [Abstract] [Full Text] [Related]
11. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older.
Driver JA; Viswanathan AN
Gynecol Oncol; 2017 Jun; 145(3):526-530. PubMed ID: 28359689
[TBL] [Abstract] [Full Text] [Related]
12. Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via smad-independent MEK-ERK1/2-SNAIL signaling.
Xiong S; Klausen C; Cheng JC; Leung PC
Oncotarget; 2016 Jun; 7(26):40060-40072. PubMed ID: 27223076
[TBL] [Abstract] [Full Text] [Related]
13. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract] [Full Text] [Related]
14. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract] [Full Text] [Related]
15. Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids.
Yin H; Lo JH; Kim JY; Marsh EE; Kim JJ; Ghosh AK; Bulun S; Chakravarti D
Mol Endocrinol; 2013 May; 27(5):726-40. PubMed ID: 23550059
[TBL] [Abstract] [Full Text] [Related]
16. A high concentration of genistein down-regulates activin A, smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
Di X; Andrews DM; Tucker CJ; Yu L; Moore AB; Zheng X; Castro L; Hermon T; Xiao H; Dixon D
Exp Mol Med; 2012 Apr; 44(4):281-92. PubMed ID: 22228119
[TBL] [Abstract] [Full Text] [Related]
17. Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms.
Cheng YH; Utsunomiya H; Pavone ME; Yin P; Bulun SE
J Mol Endocrinol; 2011 Apr; 46(2):139-53. PubMed ID: 21310893
[TBL] [Abstract] [Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.
Halder SK; Goodwin JS; Al-Hendy A
J Clin Endocrinol Metab; 2011 Apr; 96(4):E754-62. PubMed ID: 21289245
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical localization of inhibin and activin subunits, activin receptors and smads in ovarian endometriosis.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Int J Mol Med; 2010 Jan; 25(1):17-23. PubMed ID: 19956897
[TBL] [Abstract] [Full Text] [Related]
20. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract] [Full Text] [Related]
[Next]
